109 related articles for article (PubMed ID: 31692891)
21. An overview of MCT1 and MCT4 in GBM: small molecule transporters with large implications.
Park SJ; Smith CP; Wilbur RR; Cain CP; Kallu SR; Valasapalli S; Sahoo A; Guda MR; Tsung AJ; Velpula KK
Am J Cancer Res; 2018; 8(10):1967-1976. PubMed ID: 30416849
[TBL] [Abstract][Full Text] [Related]
22. The kinetics, substrate and inhibitor specificity of the lactate transporter of Ehrlich-Lettre tumour cells studied with the intracellular pH indicator BCECF.
Carpenter L; Halestrap AP
Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):751-60. PubMed ID: 7818477
[TBL] [Abstract][Full Text] [Related]
23. Lactate transport in rat adipocytes: identification of monocarboxylate transporter 1 (MCT1) and its modulation during streptozotocin-induced diabetes.
Hajduch E; Heyes RR; Watt PW; Hundal HS
FEBS Lett; 2000 Aug; 479(3):89-92. PubMed ID: 10981713
[TBL] [Abstract][Full Text] [Related]
24. The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond.
Halestrap AP; Meredith D
Pflugers Arch; 2004 Feb; 447(5):619-28. PubMed ID: 12739169
[TBL] [Abstract][Full Text] [Related]
25. Molecular basis of ligand recognition and transport by glucose transporters.
Deng D; Sun P; Yan C; Ke M; Jiang X; Xiong L; Ren W; Hirata K; Yamamoto M; Fan S; Yan N
Nature; 2015 Oct; 526(7573):391-6. PubMed ID: 26176916
[TBL] [Abstract][Full Text] [Related]
26. Transfer of glycogen-derived lactate from astrocytes to axons via specific monocarboxylate transporters supports mouse optic nerve activity.
Tekkök SB; Brown AM; Westenbroek R; Pellerin L; Ransom BR
J Neurosci Res; 2005 Sep; 81(5):644-52. PubMed ID: 16015619
[TBL] [Abstract][Full Text] [Related]
27. Monocarboxylate Transporters: Therapeutic Targets and Prognostic Factors in Disease.
Jones RS; Morris ME
Clin Pharmacol Ther; 2016 Nov; 100(5):454-463. PubMed ID: 27351344
[TBL] [Abstract][Full Text] [Related]
28. Kinetic analysis of L-lactate transport in human erythrocytes via the monocarboxylate-specific carrier system.
De Bruijne AW; Vreeburg H; Van Steveninck J
Biochim Biophys Acta; 1983 Aug; 732(3):562-8. PubMed ID: 6871216
[TBL] [Abstract][Full Text] [Related]
29. Functional characteristics of the cardiac sarcolemmal monocarboxylate transporter.
Trosper TL; Philipson KD
J Membr Biol; 1989 Nov; 112(1):15-23. PubMed ID: 2593136
[TBL] [Abstract][Full Text] [Related]
30. Clinical and Functional Relevance of the Monocarboxylate Transporter Family in Disease Pathophysiology and Drug Therapy.
Fisel P; Schaeffeler E; Schwab M
Clin Transl Sci; 2018 Jul; 11(4):352-364. PubMed ID: 29660777
[TBL] [Abstract][Full Text] [Related]
31. The role of monocarboxylate transporter 2 and 4 in the transport of gamma-hydroxybutyric acid in mammalian cells.
Wang Q; Morris ME
Drug Metab Dispos; 2007 Aug; 35(8):1393-9. PubMed ID: 17502341
[TBL] [Abstract][Full Text] [Related]
32. Spatial expression and functional flexibility of monocarboxylate transporter isoforms in the zebrafish brain.
Tseng YC; Kao ZJ; Liu ST; Chen RD; Hwang PP
Comp Biochem Physiol A Mol Integr Physiol; 2013 Jun; 165(2):106-18. PubMed ID: 23384686
[TBL] [Abstract][Full Text] [Related]
33. Characterisation of human monocarboxylate transporter 4 substantiates its role in lactic acid efflux from skeletal muscle.
Manning Fox JE; Meredith D; Halestrap AP
J Physiol; 2000 Dec; 529 Pt 2(Pt 2):285-93. PubMed ID: 11101640
[TBL] [Abstract][Full Text] [Related]
34. The expression of monocarboxylate transporters in thyroid carcinoma can be associated with the morphological features of BRAF
Rossi ED; Bizzarro T; Granja S; Martini M; Capodimonti S; Luca E; Fadda G; Lombardi CP; Pontecorvi A; Larocca LM; Baltazar F; Schmitt F
Endocrine; 2017 May; 56(2):379-387. PubMed ID: 27484771
[TBL] [Abstract][Full Text] [Related]
35. Monocarboxylate transporters: past, present, and future.
Merezhinskaya N; Fishbein WN
Histol Histopathol; 2009 Feb; 24(2):243-64. PubMed ID: 19085840
[TBL] [Abstract][Full Text] [Related]
36. Effects of streptozotocin-induced diabetes on markers of skeletal muscle metabolism and monocarboxylate transporter 1 to monocarboxylate transporter 4 transporters.
Py G; Lambert K; Milhavet O; Eydoux N; Préfaut C; Mercier J
Metabolism; 2002 Jul; 51(7):807-13. PubMed ID: 12077722
[TBL] [Abstract][Full Text] [Related]
37. Alternative-substrate inhibition of L-lactate transport via the monocarboxylate-specific carrier system in human erythrocytes.
de Bruijne AW; Vreeburg H; van Steveninck J
Biochim Biophys Acta; 1985 Feb; 812(3):841-4. PubMed ID: 3970911
[TBL] [Abstract][Full Text] [Related]
38. Identification of a selective inhibitor of human monocarboxylate transporter 4.
Futagi Y; Kobayashi M; Narumi K; Furugen A; Iseki K
Biochem Biophys Res Commun; 2018 Jan; 495(1):427-432. PubMed ID: 28993194
[TBL] [Abstract][Full Text] [Related]
39. In situ coexpression of glucose and monocarboxylate transporter mRNAs in metabolic-sensitive caudal dorsal vagal complex catecholaminergic neurons: transcriptional reactivity to insulin-induced hypoglycemia and caudal hindbrain glucose or lactate repletion during insulin-induced hypoglycemia.
Briski KP; Cherian AK; Genabai NK; Vavaiya KV
Neuroscience; 2009 Dec; 164(3):1152-60. PubMed ID: 19744543
[TBL] [Abstract][Full Text] [Related]
40. Helix 8 and helix 10 are involved in substrate recognition in the rat monocarboxylate transporter MCT1.
Rahman B; Schneider HP; Bröer A; Deitmer JW; Bröer S
Biochemistry; 1999 Aug; 38(35):11577-84. PubMed ID: 10471310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
